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Abstract—Previous work has shown that c-Myc is required for adequate vasculogenesis and angiogenesis. To further
investigate the contribution of Myc to these processes, we conditionally expressed c-Myc in embryonic endothelial cells
using a tetracycline-regulated system. Endothelial Myc overexpression resulted in severe defects in the embryonic
vascular system. Myc-expressing embryos undergo widespread edema formation and multiple hemorrhagic lesions.
They die between embryonic days 14.5 and 17.5. The changes in vascular permeability are not caused by deficiencies
in vascular basement membrane composition or pericyte coverage. However, the overall turnover of endothelial cells
is elevated as is revealed by increased levels of both proliferation and apoptosis. Whole-mount immunohistochemical
analysis revealed alterations in the architecture of capillary networks. The dermal vasculature of Myc-expressing
embryos is characterized by a reduction in vessel branching, which occurs despite upregulation of the proangiogenic
factors vascular endothelial growth factor-A and angiopoietin-2. Thus, the net outcome of an excess of vascular
endothelial growth factor-A and angiopoietin-2 in the face of an elevated cellular turnover appears to be a defect in
vascular integrity. (Circ Res. 2009;104:1151-1159.)
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Vascular development of the mouse embryo is governedby complex molecular and cellular processes and in-
volves 2 distinct mechanisms. Vasculogenesis is responsible
for de novo generation of vessels from angioblasts and occurs
during the formation of the primitive vascular plexus in
extraembryonic tissues and within the embryo. Angiogenesis
subsumes formation of new vascular structures from preex-
isting vessels by sprouting and intussusception.1 The imma-
ture vascular tree adjusts to changes in blood flow and
oxygen demand by remodeling. This involves both new
vessel growths by sprouting or intussusception, as well as
vessel regression, a process called pruning. These processes
result in a hierarchically organized vascular pattern that
facilitates directional blood flow.2 Later phases of vascular
development involve the differential recruitment of associ-
ated support cells, such as smooth muscle cells and pericytes
and the formation of vascular basement membranes.1
Key molecular regulators of early vascular development
are vascular endothelial growth factor (VEGF)-A and its
cognate receptors VEGFR-1 and VEGFR-2. Mice with mu-
tations in either VEGF-A or the receptors show severe defects
in blood vessel formation and die early in embryogenesis
before the establishment of blood circulation. Heterozygous
VEGF-A embryos also show a lethal phenotype suggesting
that fine-tuned regulation of components of the VEGF/
VEGFR system is essential for correct vascular
differentiation.3
Vascular remodeling and vessel stabilization depend on the
angiopoietin (Ang)/Tie pathway.3 The 2 Tie receptors, Tie1
and Tie2/Tek, encode receptor tyrosine kinases predomi-
nantly expressed in endothelial cells.4 Tie2 expression is
detectable starting in angioblasts and throughout develop-
ment with reduced expression in quiescent endothelial cells.1
Angiopoietins, the ligands for the Tie2 receptor have different
functions during vascular development. Ang-1 acts to stabi-
lize vessels, whereas Ang-2 can have antagonistic as well as
agonistic activity depending on the tissue context and envi-
ronmental conditions. Ang-2 can locally antagonize Ang-1–
mediated Tie2 activation and therefore cause destabilization
of vessels. In the presence of both Ang-2 and VEGF-A,
angiogenesis can occur; in the absence of VEGF-A, Ang-2
destabilizes vessels, leading to endothelial cell apoptosis and,
thereby, to vessel regression.3
The Myc protein is known to regulate several aspects of
blood vessel formation. Myc contains a bHLH (basic helix–
loop–helix) leucine zipper motif and binds to conserved
DNA motives (E-boxes) after dimerization with its partner
protein Max. Myc activity is tightly regulated and it is only
expressed when cells actively divide. The Myc/Max het-
erodimer both activates transcription but can also mediate
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gene repression.5 Myc represses expression of the antian-
giogenic factor thrombospondin-16 and stimulates the
proangiogenic factor VEGF-A.7 Furthermore, many genes
critical for diverse cellular functions like cell cycle pro-
gression, apoptosis, and metabolism have been identified
as Myc target genes.8
Homozygous c-myc–null mutation leads to lethality at
embryonic developmental day (E)10.5.9 Mutant embryos
were growth-retarded and showed defects in cardiac and
neuronal development, as well as in primitive erythropoiesis.
Moreover, both vasculogenesis and angiogenesis were dis-
torted and this was manifested in an altered expression of
direct and indirect Myc target genes.7 A recent analysis of
endothelial cell–selective Myc deletion concluded that the
vascular phenotype observed in these mouse embryos may
not be attributable to an endothelial cell–autonomous effect
of Myc.10
To determine the consequence of Myc upregulation in
endothelial cells for their development, proliferation, and
survival, we used a model of endothelial cell–specific condi-
tional expression of Myc. Remarkably, overexpression results
in embryonic lethality and embryos show severe edema and
hemorrhages. Our results demonstrate that fine-tuned regula-
tion of Myc target genes is essential for proper vascular
remodeling and the maintenance of vascular integrity.
Materials and Methods
An expanded Materials and Methods section is available in the
online data supplement at http://circres.ahajournals.org.
Quantitative Analysis of Dermal
Vascular Architecture
For the quantitative analysis of vessel morphology, the blood vessels
were regarded as a random network of line segments neglecting their
width and curvature. Gray scale images of blood vessels were
skeletonized using different image processing techniques and then
transformed into a network of line segments as described previously.11
Based on the network of line segments, different statistical
characteristics describing the spatial geometric structure, such as the
mean number of branching points and line segments, both measured
per unit area, and, in addition, the mean length of the segments, were
estimated by unbiased estimators described elsewhere.12 The Wil-
coxon signed rank test was used for statistical calculation. A
probability value of 0.01 was considered statistically significant.
Results
To target c-Myc expression to the endothelium, mice carrying
a tet operator–driven human c-Myc transgene and luciferase
reporter gene (tetO-Myc)8 were crossed with a second trans-
genic mouse line (Tie2-tTA) that expresses the tetracycline-
controlled transactivator under the control of the murine
endothelial cell–specific Tie2 promoter/enhancer elements
(Figure 1a).13 In the absence of tetracycline/doxycycline, this
gene expression system is turned on. Addition of doxycycline
shuts off Myc transgene expression. During pregnancy, mice
were treated either with doxycycline, added to the drinking
water, or left untreated. To assess tTA-mediated Myc expres-
sion, RNA was isolated from the lungs of E14.5 embryos.
RT-PCR analysis revealed that Myc expression was only
detectable in Tie2-tTA/tetO-Myc (double-transgenic) em-
bryos from non–doxycycline-treated mothers (Figure 1b).
The Myc transgene is expressed from a bidirectional pro-
moter that allows luciferase gene transcription in the opposite
direction. We observed high luciferase expression levels
exclusively in non–doxycycline-treated double-transgenic
embryos (Figure 1c). Finally, even though endothelial cells
represent only a subset of cells in the lung, we were still able
to detect increased Myc protein levels in double-transgenic
embryos as compared to wild-type or single-transgenic con-
trols (Figure 1d and data not shown).
The analysis of offspring from mothers not treated with
doxycycline during pregnancy revealed no living double-
transgenic animals. However, double-transgenic mice were
born at the expected Mendelian frequency when the pregnant
mothers were treated with doxycycline in the drinking water
(Online Table I). Litters of dams not treated with doxycycline
were analyzed at different time points of gestation to deter-
Figure 1. Conditional expression of transgenic Myc in endotheli-
al cells. a, Constructs for Myc endothelial cell–specific expres-
sion in transgenic mice. Transgenic mice expressing the trans-
activator under the control of the Tie2 promoter/enhancer
construct (tet-off system). The tetO-Myc mice carry the Myc
gene under the control of a bidirectional promoter (coexpressing
luciferase). b, Expression of the human c-Myc transgene was
measured in the lungs of E14.5 embryos by RT-PCR. The lower
gel shows a control RT-PCR for -actin. Genotypes of mouse
embryos are indicated at the top. Pregnant mothers were
treated with doxycycline or left untreated to control the tet-off
system as indicated. c, Luciferase activities were measured in
E14.5 embryonic lung protein extracts. The respective geno-
types and doxycycline treatment are indicated. A representative
experiment is shown. d, Western blot analysis of Myc protein
expression in E14.5 embryonic lungs of 1 wild-type and 2
double-transgenic embryos. Genotypes are indicated. Expres-
sion of -actin was determined as a control.
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mine when embryos die. Double-transgenic embryos with a
normal appearance were present at normal frequency up to
E12.5. The exact time point of death was somewhat variable
among individual embryos. Some of the Tie2-tTA/tetO-Myc
embryos had already died at E14.5, most of the animals died
by E16.5, and no living double-transgenic animal survived to
E18.5 (Figure 2a). Double-transgenic embryos displayed
subcutaneous edema (Figure 2b, top, embryo on the right and
Figure 2c) and subsequently developed hemorrhages (Figure
2b, bottom).
One possible cause of increased vascular permeability
could be impaired tight junction formation. Therefore, ex-
pression of junctional proteins such as ZO-1, ZO-2,
claudin-5, and occludin was assessed in embryonic skin.
Immunofluorescence analyses revealed no significant
changes in expression of these junctional proteins (Figure 3a
and Online Figure II). To test whether edema formation was
associated with an immature vascular phenotype, we ana-
lyzed the distribution of pericytes along the vasculature,
which are required for stabilization of maturing vessels.
Pericyte staining with an NG2-specific antibody did not
reveal obvious differences between control and subcutaneous
edematous tissues of double-transgenic embryos (Figure 3b).
We also investigated the integrity of the basement membrane
in the dermal vasculature. Laminin expression and organiza-
tion was normal in double-transgenic animals (Online Figure
III, a). In addition, organization of smooth muscle cells
covering dermal arteries was analyzed with an -smooth
muscle actin antibody, and again no differences were ob-
served (Online Figure III, b). Matrix metalloproteinases
(MMPs) are responsible for remodeling of the extracellular
matrix during development and disease.14 Because Myc was
shown to induce MMP-9 expression in endothelial cells, we
assessed MMP-9 protein levels. Slightly increased MMP-9
protein expression levels were noticed in the lungs of double-
transgenic embryos at E15.5 (Online Figure III, c).
Edema formation could also be attributable to lymphatic
dysfunction. Therefore, the lymphatic vasculature of E14.5
embryos was assessed with LYVE-1–specific antibodies
(Online Figure IV). This analysis revealed no differences
between lymphatic vessels of control and Tie2-tTA/tetO-Myc
embryos. Further immunohistological analysis showed that
lymphatic vessels were intact, and no blood cells were present
in lymphatic vessels adjacent to blood vessels (Figure 3c, left
images). Examination of both blood and lymphatic vessels
revealed that Tie2-tTA/tetO-Myc embryos have unaltered
numbers of normally sized lymphatic vessels in the dermis
and in the jugular area (Figure 3c, middle and right images).
Subsequently, ultrastructural analyses of embryonic endo-
thelium at stage E14.5 were performed by transmission
electron microscopy. At least 20 vessels per section of 7
Tie2-tTA/tetO-Myc or control embryonic skins were investi-
gated. The majority of vessels in wild-type and single-
transgenic control embryos were intact (Figure 4a). However,
in some cases, the surface of endothelial cells was enlarged
(Figure 4b) or endothelial cells were necrotic or the circum-
ference of the endothelial lining was discontinuous, leading to
local diapedesis of erythroblasts (data not shown). Approxi-
mately 300 vessel profiles were inspected on multiple sec-
tions without any indication of apoptosis. In contrast, the
blood vessels of double-transgenic mice frequently revealed
individual apoptotic cells interspersed within apparently nor-
mal endothelium (Figure 4c through 4f). Apoptotic cells were
found between completely normal endothelial cells with
apparently intact tight junctions between the apoptotic and
the normal cell (Figure 4c). A total of 80% of vessel profiles
showed single apoptotic figures. Apoptosis of individual
endothelial cells could well result in a breach of the vascular
barrier and thus in a strongly increased permeability and an
accumulation of fluid in the interstitium. In other cases, 40%
of the vessel profiles showed apoptotic figures and the
endothelial lining was completely destroyed, resulting in a
loss of contacts between individual cells (Figure 4d and 4e).
It is noteworthy that endothelial tight junctions, which con-
stitute the structural and functional elements of the vascular
Figure 2. Endothelial cell–specific Myc expression results in
embryonic lethality. a, Survival rate of Tie2-tTA/tetO-Myc trans-
genic embryos derived from crosses without doxycycline. A
total of 66 double-transgenic Tie2-tTA/tetO-Myc embryos were
scored out of 231 embryos in total at the indicated days of
embryonic development. Genotypes were determined both by
luciferase measurements, as well as PCR analyses. Beating of
the heart was used to distinguish between living and dead
embryos. Single transgenic or wild-type animals were used as
controls. b, Gross appearance of embryos at E16.5. Note the
widespread subcutaneous edema (red arrowhead, upper right)
and multifocal hemorrhages (white arrowheads) on the extremi-
ties (upper right and lower right) and head (lower left). None of
these alterations was seen in control littermates (embryo at the
upper left). Scale bars: 2 mm (top); 400 m (lower left); 350 m
(lower right). c, Hematoxylin/eosin staining of sagittal sections of
E15.5 embryos. Widespread subcutaneous edema is visible.
Scale bar: 2 mm.
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permeability barrier, remained unchanged in the vasculature
of double-transgenic embryos, except between 2 neighboring
apoptotic cells (Figure 4d and 4e, arrows). In 2 of 7
Tie2-tTA/tetO-Myc embryos, an extreme condition was
reached, when endothelial cells were completely dissolved in
apoptotic bodies (Figure 4f); such defects were never found
in wild-type or single-transgenic embryos.
Previous experiments have documented a critical role of
Myc in regulating both cell proliferation and apoptosis. To
determine whether Myc affected these processes, apoptosis
and proliferation of embryonic endothelial cells were mea-
sured in control and double-transgenic embryos (Online
Figure V). This analysis revealed a 1.5- to 2-fold increase of
apoptotic endothelial cells in double-transgenic embryos at
E14.5 and E15.5, respectively (Figure 5a). Interestingly, there
is a compensatory increase in the number of proliferating
(Ki67-positive) cells (Figure 5b) at E15.5. The net result of
increased apoptosis and proliferation is a largely unaltered
absolute number of endothelial cells (Figure 5c), apparently
at the expense of blood vessel integrity.
Myc-deficient mice die at E10.5 with defects in vasculo-
genesis and angiogenesis7; however, a recent analysis sug-
gests that this is largely attributable to Myc activity in
hematopoietic cells.10 We therefore analyzed the embryonic
vasculature in our model in more detail. Whole-mount
stainings were performed using antibodies specific for the
endothelial cell marker CD31/platelet endothelial cell adhe-
sion molecule (PECAM)-1. No obvious differences were
found in E9.5 embryos suggesting that vasculogenesis oc-
curred normally (Online Figure VI). However, the vascular
network in E14.5 Myc-overexpressing embryos was signifi-
cantly different. Fewer branches were formed, indicating
defective angiogenesis or enhanced pruning of vessels (Fig-
ure 6a). To quantify these alterations, statistical analyses were
performed on distinct parameters that define the vascular
network. The degree of branching was determined as the
number of branching points per area, as well as the number
and mean length of vessels (for details on the statistical
analysis, see Materials and Methods). These analyses re-
vealed a striking reduction in branching points and corre-
spondingly fewer vessels in the double-transgenic animals
(Figure 6b, upper panels). Consistent with this sparsity of
segments, the mean length of a vessel in between branching
points was increased (Figure 6b, lower left graph). In addi-
tion, we also counted vessel sprouts that had not successfully
connected to another vessel. The number of such sprouts was
clearly increased in double-transgenic animals as compared
to controls (Figure 6b, lower right graph), indicating an
increase in ongoing but not yet completed angiogenic activ-
ity. Statistical analysis of E13.5 embryonic back skin vascular
architecture revealed no significant differences in the number
of branching points, number of vessels, and the mean length
of vessels between the control and double-transgenic em-
bryos (Online Figure VII). These data suggest that blood
vessels are formed normally up to E13.5 in Tie2-tTA/tetO-
Myc embryos.
Figure 3. Characterization of vessel structure in
embryonic skin. a, Junctional protein analysis in
E14.5 embryonic dermis by immunofluorescence.
Double labeling for different junctional markers
(red), such as ZO-1, ZO-2, occludin, and claudin-5
and nuclear stain by DAPI (blue) is shown for the
indicated genotypes. Scale bar: 20 m. b, Pericyte
coverage of embryonic blood vessels was visual-
ized in E14.5 embryos by whole-mount immuno-
fluorescence. Endothelial cells were stained with
the CD31/PECAM-1 antibody (green); pericytes
were stained with the NG2 antibody (red). Scale
bar: 20 m. c, Left images show LYVE-1 immuno-
histochemical staining of lymphatic vasculature in
E14.5 embryos and CD31/PECAM-1 staining of
blood vessels from adjacent sections from wild-
type and double-transgenic embryos. Lymphatic
vessels are indicated by white arrows; blood ves-
sels are indicated by black arrows. Scale bar:
160 m. In the middle images, double-immuno-
fluorescence staining was performed with LYVE-1
(red) and CD31/PECAM-1 (green) antibodies. Scale
bar: 100 m. Quantification of lymphatic vessel
area by LYVE-1 staining on embryonic skin and
jugular area is shown in the right graphs.
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To elucidate the underlying molecular mechanisms, quan-
titative RT-PCR analysis of candidate target gene expression
was performed in isolated embryonic endothelial cells. En-
dothelial cells were purified as CD31/PECAM-1 and CD105/
endoglin double-positive cells from double-transgenic and
control embryos at E14.5. Fluorescence-activated cell-sorting
analyses revealed a 92% to 98% purity of the sorted CD31high
endothelial cells. Myc transgene expression was analyzed in
the enriched endothelial cells (Figure 7a) and detected spe-
cifically in the double-transgenic endothelial cells only. Only
low levels of luciferase expression were detected in the
CD31/CD105 double-negative cell fractions of Tie2-tTA/
tetO-Myc embryos (Figure 7b). Earlier experiments in Myc-
deficient mice had revealed that VEGF-A expression requires
Myc activity. Consistently, in endothelial cells derived from
double-transgenic embryos, we saw a more than 2-fold
upregulation of VEGF-A expression (Figure 7c). Given that
levels of VEGF-A are tightly regulated and that mutation of
a single allele of VEGF-A results in early embryonic lethal-
ity,15,16 the increased expression levels of VEGF-A are of
relevance. Importantly, we also saw an increase in the levels
of Ang-2, a proangiogenic factor and potential antagonist of
Ang-1. Ang-1 levels were only marginally affected leading to
a shift in the net Ang-1/Ang-2 balance toward a prevalence of
Figure 4. Electron microscopic analyses of dermal blood ves-
sels in Myc-overexpressing mice. a and b, Single-transgenic
mice. c through f, Double-transgenic mice. a, Normal vessel
with an erythroblast in its lumen. The endothelial cell sheet is
continuous and interconnected by tight junctions (arrows). b,
Blood vessel with apparently obliterated lumen (asterisks label
the rest of the lumen) and increased surface. Endothelial cells
are neither necrotic nor apoptotic and interconnected by tight
junctions (arrows). c, Blood vessel with normal shape and con-
tinuous lining with a single isolated apoptotic endothelial cell
(thick arrow). d, Blood vessel with an almost completely dissoci-
ated lining. Tight junctions between endothelial cells are still
found (thin arrows). Most endothelial cells are dissociated from
each other leaving gaps between them (thick arrows). Apoptotic
endothelial cells are found (A). e, Higher degree of endothelial
apoptosis (A) in a blood vessel revealed by the typical segrega-
tion and condensation of nuclear chromatin. Some endothelial
tight junctions are maintained, confirming the presence of tight
junction proteins. f, Culmination of endothelial apoptosis (A) evi-
dent by the blebbing of both nuclear and cytoplasmic apoptotic
bodies.
Figure 5. Endothelial cell proliferation and apoptosis. Flow cyto-
metric analysis was performed on cells from E14.5 and E15.5
embryos. a, Quantification of endothelial cell apoptosis using
double staining for cleaved caspase-3 and CD31/PECAM-1. In
total, 26 control animals (wild-type or single-transgenic, gray
bars) and 11 double-transgenic Tie2-tTA/tetO-Myc animals
(black bars) were analyzed. Elevated apoptosis was found in
Tie2-tTA/tetO-Myc embryos. **P0.005. b, Quantification of en-
dothelial cell proliferation using staining for the Ki67 antigen as
proliferation marker and CD31/PECAM-1 staining to identify en-
dothelial cells. Proliferation was measured in a total of 21 con-
trol embryos (wild-type or single-transgenic, gray bars) and 15
Tie2-tTA/tetO-Myc double-transgenic embryos (black bars). The
proliferation rate is substantially higher in E15.5 Tie2-tTA/tetO-
Myc embryos. *P0.05. c, Overall endothelial cell number did
not change significantly. In total, 47 controls (gray bars) and 26
Tie2-tTA/tetO-Myc embryos (black bars) were analyzed.
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Ang-2. Expression of several other candidate genes that could
explain the observed phenotype in vascular architecture and
permeability, including the notch ligand Delta-like 4, was not
altered.
Recent publications report the important role of ad-
renomedullin (AM) signaling during vascular development.
Embryos lacking either AM, or calcitonin-receptor like re-
ceptor, the mediator of AM signaling, or receptor activity
modifying protein (RAMP)-2 develop severe edema and die
at mid-gestation.17,18 We therefore assessed the expression of
AM pathway signaling molecules in sorted endothelial cells
and found a down regulation of RAMP-2 and an upregulation
of AM (Online Figure VIII). Given the increased numbers of
sprouts, we analyzed expression of platelet-derived growth
factor-B, a marker of sprouting endothelial cells, but could
not detect any differences (Online Figure VIII).
To determine whether the 2-fold increase in VEGF-A RNA
level was also reflected by an increased protein concentration,
we measured VEGF-A protein level in wild-type and Tie2-
tTA/tetO-Myc embryos by a VEGF-A–specific ELISA. This
analysis revealed increased VEGF-A levels in Myc-
expressing embryos at all time points of embryonic develop-
ment analyzed (Figure 7d).
Discussion
In Tie2-tTA/tetO-Myc embryos, the vasculature established
during vasculogenesis and angiogenesis was normal until
E13.5. Blood vessels in edematous areas of the embryonic
skin at E14.5 still had normal vessel morphology with fully
developed basement membranes, extracellular matrix, and an
intact pericyte and smooth muscle cell cover. However,
electron microscopic investigations revealed accumulations
of interspersed apoptotic endothelial cells, which could ex-
plain, at least in part, the interruption of vascular integrity and
increased vessel permeability. Importantly, tight junctions
were intact between endothelial cells, indicating that tight
junctional failures did not critically contribute to vascular
leakage.
The mitogenic and proapoptotic properties of Myc are
genetically inseparable. Ectopic expression of Myc is suffi-
cient to drive many cells into the cell cycle even in the
absence of external mitogens. However, Myc also promotes
apoptosis, although the precise mechanisms by which this
occurs have not been completely elucidated.19 Therefore, it is
not unexpected that endothelial cell–specific expression of
c-Myc results in elevated cell cycle progression and at the
same time increased levels of apoptosis. Although these 2
Figure 6. Morphometric analyses of back skin
vascular architecture from control and Tie2-
tTA/tetO-Myc embryos at E14.5. a, Represen-
tative images of CD31/PECAM-1 whole-mount
immunofluorescence stainings used for mor-
phometric analyses. Identical magnification was
used for both images. In all cases, identical
anatomic areas from the back of the embryos
were analyzed. The obvious morphological dif-
ferences between control and Tie2-tTA/tetO-
Myc embryos are quantified below. Scale bars:
100 m. b, Branching points per area, vessel
number per area, mean vessel length, and
number of incomplete sprouts per image were
quantified in control (wild-type or single-
transgenic) and Tie2-tTA/tetO-Myc embryos. In
both groups, a total of 6 animals and 2 images
per animal were analyzed. *P0.01 (Wilcoxon
test).
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effects are balanced with no overall loss of endothelial cells,
these processes could lead to transient impairment of endo-
thelial integrity that might contribute to the observed
leakiness.
In addition, our analyses revealed a second mechanism by
which c-Myc expression might affect vascular permeability.
Expression levels of VEGF-A were found to be elevated
significantly both by RNA and protein analyses in double-
transgenic endothelial cells. VEGF-A induces vascular leak-
age and is also known as vascular permeability factor.20 The
levels of VEGF-A expression during embryogenesis need to
be tightly regulated. It has been shown that 2- to 3-fold
overexpression of VEGF-A results in severe abnormalities in
embryonic heart development, edema formation, and embry-
onic lethality at E12.5 to E14.21,22 On the other hand,
inactivation of a single VEGF-A allele in mice already
resulted in embryonic lethality between E11 and E12.15,16
Previously, it has been reported that VEGF-A expression is
reduced in Myc-deficient mice, and an indirect mechanism of
gene regulation by c-Myc was proposed.7 Our results mirror
these earlier reports, because we saw a comparable increase
of VEGF-A levels in c-Myc–overexpressing endothelial
cells.
In addition to its strong angiogenic effect, VEGF-A over-
expression in mouse skin induced enlargement of lymphatic
vessels.23 Moreover, several studies suggest that VEGF-A/
VEGFR-2 signaling may also directly affect the lymphatic
endothelium.3,24,25 We therefore analyzed the gross structure
of lymphatic vessels in double-transgenic mice but did not
detect any obvious alterations. Thus, the edema observed in
Tie2-tTA/tetO-Myc double-transgenic embryos apparently is
not the result of compromised lymph vessel function.
Mouse embryos lacking AM signaling have also been
shown to develop massive edema resulting from combined
defects in both blood and lymphatic vessels.26 We found that
RAMP-2 is slightly downregulated in Tie2-tTA/tetO-Myc
double-transgenic embryos, and AM expression is enhanced,
most likely to compensate for the deficiency in functional
AM receptors. Importantly, Tie2-tTA/tetO-Myc embryos
show a normally developed lymphatic vasculature, suggest-
ing that this reduced AM signaling did not affect lymphatic
development.
Ang-2 plays an important role in the regulation of vascular
remodeling. It can destabilize the endothelium and thereby
prime it to acquire responsiveness to other growth factors. In
the presence of VEGF-A, Ang-2 cooperates with VEGF-A to
promote sprouting, proliferation, and migration of endothelial
cells. By contrast, in the absence of VEGF-A, Ang-2 upregu-
lation promotes vascular destabilization and subsequent ves-
sel regression.27 Although Tie2-tTA/tetO-Myc embryos have
elevated amounts of VEGF-A and an even further elevated
expression of Ang-2, they do not show an increase in
angiogenesis as might be expected. Instead, elevated expres-
sion of VEGF-A and Ang-2 in endothelial cells is accompa-
nied by inadequate vascular remodeling, which results in the
establishment of an aberrant blood vessel architecture. De-
spite an increased number of apparently abortive vascular
sprouts, the deficiency in vessel density is not successfully
compensated. We propose that these vascular phenotypes are
Figure 7. Expression of angiogenic modulators in sorted E14.5
transgenic endothelial cells. a, Expression of transgenic human
c-Myc mRNA was determined by RT-PCR in sorted endothelial
cells from double-transgenic and wild-type control embryos.
Endothelial cell preparation was 92% to 98% CD31-positive. b,
Transgene expression is specific for the enriched endothelial
cell population. Luciferase measurements were performed on
10 000 sorted cells. The double-positive (CD31/CD105) endo-
thelial cell fraction and the double-negative (CD31/CD105)
cell fraction from double-transgenic Tie2-tTA/tetO-Myc, as well
as control, embryos were analyzed. As expected, Tie2-tTA/tetO-
Myc embryos show high luciferase activity. c, Expression of
angiogenic regulators in embryonic endothelial cells. Real-time
quantitative PCR analyses of sorted endothelial cells from wild-
type (gray bars) and double-transgenic Tie2-tTA/tetO-Myc
embryos (black bars). SEM is shown as error bars. *P0.05. d,
VEGF-A expression was determined by ELISA measurements.
The VEGF-A concentration was normalized against the total
protein in the tissue sample. VEGF-A levels were increased in
lungs from double-transgenic Tie2-tTA/tetO-Myc embryos from
E13.5 onward. SEM is shown as error bars. *P0.05,
**P0.005.
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the consequence of a perturbed ratio of proliferation and
apoptosis induced by Myc overexpression in endothelial
cells. Myc-induced expression of the proangiogenic factors
VEGF-A and Ang-2 is not sufficient to compensate for the
dysregulation of proliferation and cell death induced in
Myc-expressing endothelial cells (Figure 8).
Several recently published studies28–33 have demonstrated
that Notch signaling regulates the sprouting and branching
behavior in vessels by influencing the differentiation, migra-
tion, and proliferation of vascular tip cells. Reduced Notch
signaling results in increased numbers of tip cells, filopodia
extension, and vessel branching.34 The Notch ligand Delta-
like-4 has been shown to mediate these effects. We have
analyzed Delta-like-4 expression in the embryonic endothe-
lial cells but did not find any evidence for alterations. The
analysis of platelet-derived growth factor-B expression as
sprout marker revealed no differences between Tie2-tTA/
tetO-Myc and control embryos. Therefore, sprouts could be a
result of an elevated angiogenic activity triggered because of
elevated VEGF-A expression. Alternatively, sprout-like fig-
ures could arise as result of vessel involution caused by
endothelial cell apoptosis.
The role of Myc in vasculogenesis and angiogenesis in
different cell types has been addressed in a recent study,10
where the c-myc gene was deleted cell type-specifically in
80% of endothelial cells. This still allowed the development
of a largely normal vascular system. However, when Myc is
also deleted in the hematopoietic system, angiogenesis is
severely affected. Our results on conditional endothelium-
specific expression of c-Myc extend these earlier studies.7,10
Both loss of Myc and its overexpression are incompatible
with normal vessel development. These data imply that
fine-tuned expression of c-myc during vasculogenesis and
angiogenesis is a prerequisite for the establishment and/or
maintenance of functional vascular structures, and they iden-
tify at least some of the Myc-regulated mediators in these
processes.
Combining the results of the c-Myc knockout studies with
our analyses, it is evident that c-Myc is required for proper
vascular development. Myc plays a role both in endothelial
cells as well as in interacting compartments. The studies
reveal that Myc coordinates the expression of angiogenic
factors required for normal and pathological vascular
development.
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ical help; and Gabi Frommer-Kästle for technical assistance with
electron microscopical preparations.
Sources of Funding




Figure 8. Model illustrating the role of Myc during embryonic vascular development. a, In wild-type embryos, vasculogenesis, angio-
genesis, vessel maturation, and stabilization occurs in a highly coordinated manner. These processes are controlled by the balanced
expression of angiogenic modulators. b, In the presence of excess Myc activity in endothelial cells, vasculogenesis and angiogenesis
occur normally up to E13.5. However, during consecutive blood vessel formation Myc affects expression of angiogenic regulators and
endothelial cell turnover. Elevated VEGF-A and Ang-2 levels contribute to vascular hyperpermeability and edema. In addition, endotheli-
al cell apoptosis results in a leaky vascular network and finally hemorrhages. Moreover, elevated expression of proangiogenic factors
VEGF-A and Ang-2 impairs vessel remodeling and results in aberrant vascular architecture and immature vasculature with ongoing
angiogenic activities.
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